Opioid dependence treatment: options in pharmacotherapy

Expert Opinion on Pharmacotherapy
Angela L StottsThomas R Kosten

Abstract

The development of effective treatments for opioid dependence is of great importance given the devastating consequences of the disease. Pharmacotherapies for opioid addiction include opioid agonists, partial agonists, opioid antagonists, and alpha-2-adrenergic agonists, which are targeted toward either detoxification or long-term agonist maintenance. Agonist maintenance therapy is currently the recommended treatment for opioid dependence due to its superior outcomes relative to detoxification. Detoxification protocols have limited long-term efficacy, and patient discomfort remains a significant therapy challenge. Buprenorphine's effectiveness relative to methadone remains a controversy and may be most appropriate for patients in need of low doses of agonist treatment. Buprenorphine appears superior to alpha-2 agonists, however, and office-based treatment with buprenorphine in the USA is gaining support. Studies of sustained-release formulations of naltrexone suggest improved effectiveness for retention and sustained abstinence; however, randomized clinical trials are needed.

References

Sep 16, 1978·Lancet·M S GoldHerbert Kleber
Mar 1, 1977·Archives of General Psychiatry·E C SenayW Thornton
Sep 1, 1990·Acta Psychiatrica Scandinavica·Leif GrönbladhL M Gunne
Jun 1, 1985·The International Journal of the Addictions·Kenzie L Preston, G E Bigelow
Sep 1, 1985·The American Journal of Psychiatry·T J CrowleyM Macdonald
Jan 1, 1985·Journal of Substance Abuse Treatment·Herbert Kleber
Jul 1, 1988·Drug and Alcohol Dependence·Michael Gossop
May 1, 1988·British Journal of Addiction·E ViningHerbert Kleber
Jan 1, 1987·The American Journal of Drug and Alcohol Abuse·Herbert KleberThomas R Kosten
Apr 1, 1985·Archives of General Psychiatry·Herbert KleberC O'Connor
Sep 1, 1985·Clinical Pharmacology and Therapeutics·J CamíB Ugena
Sep 1, 1985·Drug and Alcohol Dependence·C Nora ChiangR L Foltz
Jun 19, 1969·The New England Journal of Medicine·V P DoleE Caine
Jan 1, 1981·Annals of the New York Academy of Sciences·M S Gold, A C Pottash
Jan 1, 1981·The American Journal of Drug and Alcohol Abuse·R A GreensteinA Vittor
Sep 1, 1980·The American Journal of Psychiatry·A M Washton, R B Resnick
May 1, 1995·Journal of General Internal Medicine·Patrick G O'ConnorRichard S Schottenfeld
Jan 1, 1994·Journal of Addictive Diseases·Leslie AmassJ R Hughes
Jan 1, 1995·Journal of Substance Abuse Treatment·G GerraM Passeri
Nov 1, 1994·Addiction·Michael Farrell
Jul 1, 1994·The American Journal of Psychiatry·Eric C StrainG E Bigelow
Feb 1, 1994·Drug and Alcohol Dependence·V NavaratnamS M Mansor
May 1, 1994·Clinical Pharmacology and Therapeutics·S L WalshG E Bigelow
Jul 1, 1993·Journal of Substance Abuse Treatment·A K NigamB M Tripathi
Jun 1, 1993·The Journal of Nervous and Mental Disease·Thomas R KostenJ Falcioni
Nov 1, 1995·Drug and Alcohol Dependence·R E JohnsonG E Bigelow
Nov 1, 1996·The American Journal of Drug and Alcohol Abuse·Patrick G O'ConnorB J Rounsaville
Jan 1, 1997·The American Journal on Addictions·M A MarrazziE D Luby
Jun 1, 1997·Biological Psychiatry·J MendelsonS Batki
Oct 6, 1997·Annals of Internal Medicine·Patrick G O'ConnorB J Rounsaville
Jan 16, 1998·The American Journal of Medicine·Patrick G O'ConnorS S O'Malley
Aug 7, 1999·Journal of Psychoactive Drugs·S Maxwell, M Shinderman
Oct 21, 1999·Drug and Alcohol Dependence·Annie UmbrichtKenzie L Preston
Dec 22, 1999·The American Journal on Addictions·J StrangMichael Gossop
Mar 15, 2000·Journal of Substance Abuse Treatment·G GerraR Delsignore
May 16, 2000·Journal of Addictive Diseases·A P AlbaneseJ C Eustace
Nov 30, 2000·The American Journal of Drug and Alcohol Abuse·V P DhopeshW M Burke
Feb 15, 2001·Drug and Alcohol Dependence·S PetitjeanD Ladewig
Feb 22, 2001·Addiction·Y ObadiaJ P Moatti
Feb 24, 2001·Journal of Psychoactive Drugs·R A RawsonWalter Ling
May 19, 2001·Australian and New Zealand Journal of Public Health·M LennéAlison J Ritter
Jul 17, 2001·Journal of Substance Abuse·S L WestC W Graham
Aug 23, 2001·Journal of Substance Abuse Treatment·G GerraR Delsignore
Jan 5, 2002·Journal of Addictive Diseases·R L DeamerJ G Prichard
Feb 2, 2002·Psychopharmacology·Sandra D ComerMarian W Fischman
May 17, 2002·The American Journal of Drug and Alcohol Abuse·David A FiellinRichard S Schottenfeld
Aug 22, 2002·Drug and Alcohol Review·Nicholas Lintzeris
Sep 11, 2002·Journal of Substance Abuse Treatment·Mary Jeanne Kreek, Frank J Vocci
Dec 6, 2002·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Michael I. FingerhoodDonald R. Jasinski
Dec 24, 2002·Journal of Substance Abuse Treatment·Jami L RothenbergEdward V Nunes
May 10, 2003·Drug and Alcohol Dependence·Rolley E JohnsonLeslie Amass
Sep 5, 2003·The New England Journal of Medicine·Paul FudalaBuprenorphine/Naloxone Collaborative Study Group
Oct 18, 2003·Drug and Alcohol Dependence·Maria-Patrizia CarrieriMANIF-2000 Study Group
Jul 15, 2004·Alcoholism, Clinical and Experimental Research·Henry R KranzlerDrugAbuse Sciences Naltrexone Depot Study Group
Dec 1, 2004·Psychiatrische Praxis·Roland EbnerChristoph Zierer
Apr 7, 2005·JAMA : the Journal of the American Medical Association·James C GarbuttVivitrex Study Group
Jun 16, 2005·Journal of Gastroenterology and Hepatology·Richard HallinanGregory J Dore
Jul 26, 2005·Biological Psychiatry·Bridget A MartellThomas R Kosten
Jul 27, 2005·Addiction·Douglas LongshoreRichard A Rawson
Aug 2, 2005·The American Journal of Psychiatry·Frank J VocciAhmed Elkashef
Aug 25, 2005·JAMA : the Journal of the American Medical Association·Eric D CollinsNicole E Heitler
Dec 13, 2005·Journal of General Internal Medicine·Linda R GowingRobert L Ali
Jan 13, 2006·Journal of Psychopharmacology·G GerraA Zaimovic
Apr 14, 2006·Current Opinion in Psychiatry·Linda R Gowing, Robert L Ali
Apr 21, 2006·The Cochrane Database of Systematic Reviews·I G NeedlemanR J Tucker
Jul 15, 2006·Alcohol·Mao-Hsiung YenJau-Shyong Hong
Dec 19, 2006·European Addiction Research·Xavier CamarasaDaniele Fabio Zullino
Mar 29, 2007·Annals of Family Medicine·Ira L MintzerSteffie Woolhandler
Jul 27, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·Hanh T T NgoGary K Hulse
Aug 8, 2007·Drug and Alcohol Dependence·Maria A SullivanEdward V Nunes
Oct 5, 2007·Current Psychiatry Reports·Frank M OrsonThomas R Kosten
Oct 13, 2007·Journal of Substance Abuse Treatment·Robert J TaitGary K Hulse
Nov 3, 2007·The American Journal of Psychiatry·Andrew Byrne, Alex Wodak
Apr 9, 2008·The American Journal on Addictions·David A FiellinRichard S Schottenfeld
Apr 24, 2008·The Medical Journal of Australia·Nicholas LintzerisPaul S Haber
Jun 28, 2008·European Addiction Research·Michelle J HorspoolNigel Mathers
Nov 6, 2008·JAMA : the Journal of the American Medical Association·George E WoodyPaul Fudala
Nov 26, 2008·Pharmacoepidemiology and Drug Safety·J S Akhurst
Jan 20, 2009·Addiction·Walter LingRichard Bilangi

Citations

Nov 5, 2013·Trends in Pharmacological Sciences·Jamie PetersTaco J De Vries
Sep 11, 2002·Biochimica Et Biophysica Acta·Stefan KerscherUlrich Brandt
Apr 9, 2013·CNS Spectrums·Thomas A NguyenStephen M Strakowski
May 1, 2012·Journal of Addictive Diseases·Mehran ZarghamiMohammad-Reza Shiran
Nov 4, 2010·British Medical Bulletin·Anne Lingford-HughesAlastair Reid
Jan 21, 2012·The Journal of Pharmacology and Experimental Therapeutics·Marco PravetoniP R Pentel
Dec 12, 2012·PloS One·Jennifer Prah RugerRichard S Schottenfeld
Jan 1, 2011·Substance Abuse : Research and Treatment·Kimberly L Kjome, F Gerard Moeller
Nov 6, 2013·Pharmacology & Therapeutics·Jeffrey M WitkinRoberto Ciccocioppo
Apr 19, 2013·Expert Opinion on Biological Therapy·Thomas R Kosten, Coreen B Domingo
Jul 16, 2010·Expert Opinion on Investigational Drugs·Marta Rodríguez-AriasJosé Miñarro
Dec 17, 2015·Journal of Addictive Diseases·Stephanie Lake, Mary Clare Kennedy
Apr 14, 2011·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Michael SoykaWFSBP Task Force on Treatment, Guidelines for Substance Use Disorders
Oct 16, 2015·Journal of Addictive Diseases·Christine TimkoChristina Garrison-Diehn
Oct 30, 2012·Progress in Neuro-psychopharmacology & Biological Psychiatry·Stéphane AlloucheNicolas Marie
Mar 20, 2012·Drug and Alcohol Dependence·Angela L StottsJoy M Schmitz
Nov 24, 2011·International Journal of Pharmaceutics·Rie YamamotoMine Kinoshita
Oct 29, 2011·Clinics in Liver Disease·Andrea DiMartiniMary Amanda Dew
Feb 2, 2011·Pediatric Clinics of North America·Gabriel Kaplan, Iliyan Ivanov
Dec 15, 2010·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Sergio Perez-AlvarezJoaquín Jordán
Aug 11, 2015·Addictive Behaviors·Stacey C SigmonRobert P Schwartz
Apr 5, 2013·Journal of Forensic Sciences·Cassie L BoggsDavid R Fowler
Mar 24, 2016·Journal of Pain & Palliative Care Pharmacotherapy·Jordan B KingBrandon K Bellows
May 6, 2015·Preventive Medicine·Stacey C Sigmon
Jul 28, 2015·Preventive Medicine·Marjorie Meyer, Julie Phillips
Jun 7, 2013·Progress in Neuro-psychopharmacology & Biological Psychiatry·Therese A KostenThomas R Kosten
Apr 23, 2015·Journal of Addiction Medicine·Edward V NunesDavid R Gastfriend
May 21, 2013·Drug and Alcohol Dependence·Evgeny M KrupitskyThomas R Kosten
Aug 28, 2012·Drug and Alcohol Dependence·Ryan VandreyDayong Lee
Oct 31, 2012·Human Vaccines & Immunotherapeutics·Maciej L Goniewicz, Marcin Delijewski
Dec 23, 2014·Journal of Substance Abuse Treatment·Christine TimkoMichael A Cucciare
Jan 28, 2014·Journal of Immunological Methods·J J TaylorMarco Pravetoni
Dec 3, 2014·Journal of Substance Abuse Treatment·Jennifer M FennStacey C Sigmon
Mar 3, 2015·Drug and Alcohol Dependence·Leslie H Lundahl, Mark K Greenwald
Mar 26, 2016·Frontiers in Psychiatry·Idaira Oliva, Matthew J Wanat
Aug 6, 2016·Current Treatment Options in Psychiatry·Georgi VasilevJasmin Vassileva
Sep 11, 2016·Child and Adolescent Psychiatric Clinics of North America·Christopher J Hammond
Jul 22, 2016·Human Vaccines & Immunotherapeutics·Marco Pravetoni
Oct 8, 2016·Psychopharmacology·Giordano de GuglielmoRoberto Ciccocioppo
May 5, 2017·Substance Abuse : Research and Treatment·Julia WooZainab Samaan
Nov 10, 2018·Nature Reviews. Drug Discovery·Ichio ShimadaKurt Wüthrich
Jun 13, 2013·Nature Reviews. Neuroscience·David J NuttDavid E Nichols
Aug 4, 2011·The Journal of Trauma·Christopher V MaaniEvan M Renz
Nov 8, 2018·The Journal of Pharmacology and Experimental Therapeutics·David R MaguireCharles P France
Nov 22, 2017·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Michael Z LiaoQingcheng Mao
Feb 28, 2020·Expert Opinion on Pharmacotherapy·Lauren E HoodM Foster Olive
May 15, 2020·PloS One·Aisling Máire O'ConnorFiona Boland
Jul 11, 2019·CNS Spectrums·Biren Patel, Thomas R Kosten
Aug 11, 2020·Drugs·Reda M Chalhoub, Peter W Kalivas
Feb 18, 2016·The Journal of Behavioral Health Services & Research·Jemima A FrimpongTina Kim
Nov 21, 2015·The American Journal on Addictions·Daryl ShorterThomas R Kosten
Apr 22, 2020·Proceedings·Madison K Bangert, Gabriel M Aisenberg
Jun 8, 2019·International Journal of Prisoner Health·Dany KhalafFadi Abou-Mrad
Oct 24, 2019·Pharmaceutical Development and Technology·Zahra MohtashamiHamid Akbari Javar
Feb 7, 2020·JA Clinical Reports·Marie Shigematsu-LocatelliMasataka Yokoyama
Apr 10, 2019·Cognitive, Affective & Behavioral Neuroscience·Henk van SteenbergenSiri Leknes
Aug 12, 2019·Developmental Psychobiology·Katrina M DaigleMarie J Hayes
Jun 20, 2019·BMC Medical Informatics and Decision Making·Joseph K NuamahRanjana K Mehta
Dec 2, 2011·Clinical Pharmacology and Therapeutics·X Y ShenThomas R Kosten
May 15, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Megan LaudenbachMarco Pravetoni
Sep 24, 2019·Mayo Clinic Proceedings·Tyler S OesterleM S Gold
Nov 29, 2019·Pharmacology, Biochemistry, and Behavior·Ewa GalajRobert Ranaldi
Apr 25, 2018·Drug and Alcohol Dependence·Nicolas J SchlienzRyan Vandrey
Apr 10, 2021·Pharmacological Reports : PR·Lucja Kudla, Ryszard Przewlocki
Apr 16, 2021·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·David A Fishbain
Feb 25, 2020·Journal of the Neurological Sciences·Tyler S OesterleM S Gold

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Spatio-Temporal Regulation of DNA Repair

DNA repair is a complex process regulated by several different classes of enzymes, including ligases, endonucleases, and polymerases. This feed focuses on the spatial and temporal regulation that accompanies DNA damage signaling and repair enzymes and processes.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Separation Anxiety

Separation anxiety is a type of anxiety disorder that involves excessive distress and anxiety with separation. This may include separation from places or people to which they have a strong emotional connection with. It often affects children more than adults. Here is the latest research on separation anxiety.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Related Papers

Psychiatric Services : a Journal of the American Psychiatric Association
Patricia Marinelli-CaseyRichard A Rawson
© 2021 Meta ULC. All rights reserved